Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: Hexylaminolevulinate and Aminolevulinic Acid Nano Emulsion Versus Methylaminolevulinate
Status: Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 02 Apr 2019
Price : $35 *
At a glance
- Drugs Aminolevulinic acid (Primary) ; Aminolevulinic acid (Primary) ; Hexyl aminolevulinate (Primary) ; Hexyl aminolevulinate (Primary) ; Methyl aminolevulinate; Methyl aminolevulinate
- Indications Basal cell cancer; Carcinoma
- Focus Therapeutic Use
- 26 Mar 2019 Planned End Date changed from 1 Dec 2022 to 1 Dec 2025.
- 26 Mar 2019 Status changed from recruiting to active, no longer recruiting.
- 30 Aug 2018 Planned number of patients changed from 99 to 117.